Cargando…
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been reported from Japan, the United States, Europe, and the Far East. Although isolates with homogeneous resistance to vancomycin (MICs = 8 microg/mL) continue to be rare, there are increasing reports of strains show...
Autores principales: | Tenover, F C, Biddle, J W, Lancaster, M V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631729/ https://www.ncbi.nlm.nih.gov/pubmed/11294734 |
Ejemplares similares
-
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
por: Ribes, S., et al.
Publicado: (2010) -
Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.
por: Rotun, S S, et al.
Publicado: (1999) -
Comparative Proteomics-Based Identification of Genes Associated with Glycopeptide Resistance in Clinically Derived Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strains
por: Chen, Hongbin, et al.
Publicado: (2013) -
Methicillin-Resistant Staphylococcus aureus
por: Tenover, Fred C., et al.
Publicado: (2004) -
Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.
por: Hageman, J C, et al.
Publicado: (2001)